Why children have to wait years for new drugs

Dalmeet Singh Chawla

Nature, 2022, vol. 612, issue 7941, S54-S55

Abstract: A shortage of participants means that paediatric trials take longer and there is less financial incentive for pharmaceutical companies.

Keywords: Drug discovery; Therapeutics; Medical research; Diseases (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-022-04346-4 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:612:y:2022:i:7941:d:10.1038_d41586-022-04346-4

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-022-04346-4

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().